首页> 外文OA文献 >Growth, Systemic Safety, and Efficacy During 1 Year of Asthma Treatment With Different Beclomethasone Dipropionate Formulations: An Open-Label, Randomized Comparison of Extrafine and Conventional Aerosols in Children

【2h】

Growth, Systemic Safety, and Efficacy During 1 Year of Asthma Treatment With Different Beclomethasone Dipropionate Formulations: An Open-Label, Randomized Comparison of Extrafine and Conventional Aerosols in Children

机译：哮喘治疗哮喘治疗的生长，全身安全性和疗效与不同的替代塞洛塞酮二丙酸二丙酸二甲酸二倍体配方：儿童外列环和常规气溶胶的开放标签，随机比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
S. Pedersen; J. Warner; U. Wahn; D. Staab; M. Le Bourgeois; E. Van Essen-Zandvliet; S. Arora; S. J. Szefler;
展开▼
作者单位

展开▼
年度 2002
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Growth, Systemic Safety, and Efficacy During 1 Year of Asthma Treatment With Different Beclomethasone Dipropionate Formulations: An Open-Label, Randomized Comparison of Extrafine and Conventional Aerosols in Children [J] . Doris Staab, Elisabeth Van Essen-Zandvliet, John Warner, Pediatrics: Official Publication of the American Academy of Pediatrics . 2002,第6期

机译：用丙酸倍氯米松不同制剂对哮喘进行治疗1年的生长，全身安全性和有效性：儿童超细和常规气雾剂的开放标签，随机比较
2. Efficacy and Safety of Extrafine Beclomethasone Dipropionate Aerosol Therapy in Children with Asthma:A Twelve-Week Placebo-Controlled Trial [J] . Michael E. Ruff, Stanley J. Szefler, Eli O. Meltzer, Pediatric asthma, allergy & immunology . 2003,第1期

机译：特级倍氯米松双丙酸酯气雾剂治疗哮喘儿童的疗效和安全性：十二周安慰剂对照试验
3. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. [J] . Wolthers OD, Walters EG Clinical therapeutics . 2011,第8期

机译：使用氯氟烃或氢氟烷烃推进剂的倍氯米松二丙酸酯吸入器对5至11岁哮喘儿童的短期小腿生长：一项为期9周的开放标签，随机，交叉，非劣效性研究。
4. Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial [O] . Kai-Michael Beeh, Piotr Kuna, Massimo Corradi, 2021

机译：干粉吸入器和加压计量吸入器的比较与COPD患者的二氯塞米松/甲酚富马酸盐/果肉氟酸酯/糖酮：TRI-D随机对照试验
5. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose [O] . Davies R.J., Stampone P., OConnor B.J. 1998

机译：氢氟烷烃-134a倍氯米松双丙酸酯超细气雾剂与氯氟烃倍氯米松二丙酸酯的等效哮喘控制量约为每日总剂量的一半

Growth, Systemic Safety, and Efficacy During 1 Year of Asthma Treatment With Different Beclomethasone Dipropionate Formulations: An Open-Label, Randomized Comparison of Extrafine and Conventional Aerosols in Children

著录项

相似文献

相关主题

期刊订阅